How Helpful Is Bevacizumab in Recurrent Glioblastoma?

    loading  Checking for direct PDF access through Ovid

Abstract

In a randomized Phase III trial, the addition of bevacizumab to lomustine did not improve overall survival in patients with recurrent glioblastoma compared to lomustine alone.

Related Topics

    loading  Loading Related Articles